BIORESORBABLE OCULAR DRUG DELIVERY DEVICE
Disclosed herein are implantable intraocular drug delivery devices structured to provide targeted and/or controlled release of a drug to a desired intraocular target tissue, and methods of implanting and methods of using such devices for the treatment of ocular diseases and disorders. In certain embodiments, some, most, or essentially all of the device is made of biodegradable materials.
1 .- 14 . (canceled)
15 . A drug delivery ocular implant for placement in a vitreous cavity of an eye, the drug delivery ocular implant comprising:
an outer shell defining an interior space;
a drug disposed within the interior space; and
a hydrogel disposed within the interior space, the hydrogel configured to control elution of the drug out of the interior space.
16 . The drug delivery ocular implant of claim 15 , wherein the hydrogel is a hydrogel plug positioned adjacent the drug within the interior space.
17 . The drug delivery ocular implant of claim 15 , wherein the hydrogel and the drug are mixed and form a hydrogel-drug mixture.
18 . The drug delivery ocular implant of claim 15 , wherein the hydrogel surrounds at least a portion of the drug within the interior space.
19 . The drug delivery ocular implant of claim 15 , wherein the outer shell is capsule-shaped.
20 . The drug delivery ocular implant of claim 15 , wherein a distal end of the outer shell is rounded and a proximal end of the outer shell is rounded.
21 . The drug delivery ocular implant of claim 15 , wherein the outer shell comprises a plurality of orifices and wherein the drug is configured to elute through the plurality of orifices.
22 . A drug delivery ocular implant for placement in a vitreous cavity of an eye, the drug delivery ocular implant comprising:
an outer shell defining a drug reservoir and comprising a plurality of orifices;
a drug disposed within the drug reservoir; and
a hydrogel disposed within the drug reservoir, wherein the drug is configured to pass through the hydrogel before elution through the outer shell.
23 . The drug delivery ocular implant of claim 22 , wherein the plurality of orifices are positioned at a first end of the outer shell and wherein a second end of the outer shell is a closed end.
24 . The drug delivery ocular implant of claim 23 , wherein the hydrogel is a hydrogel plug and wherein the drug is positioned at or near the closed end and the hydrogel plug is positioned adjacent the drug.
25 . The drug delivery ocular implant of claim 22 , wherein the drug and the hydrogel form a hydrogel-drug mixture, at least 50 percent of a volume of the hydrogel-drug mixture being the drug.
26 . The drug delivery ocular implant of claim 22 , wherein a first orifice of the plurality of orifices is positioned at or near a first end of the outer shell and a second orifice of the plurality of orifices is positioned at or near a second end of the outer shell, the second end opposite the first end.
27 . The drug delivery ocular implant of claim 22 , wherein the hydrogel surrounds the drug.
28 . The drug delivery ocular implant of claim 22 , wherein a first orifice of the plurality of orifices is positioned in a rounded first end of the outer shell.
29 . The drug delivery ocular implant of claim 28 , wherein a second orifice of the plurality of orifices is positioned in a rounded second end of the outer shell.
30 . The drug delivery ocular implant of claim 29 , wherein a third orifice of the plurality of orifices is positioned in a sidewall connecting the rounded first end and the rounded second end.
31 . A drug delivery ocular implant for placement in a vitreous cavity of an eye, the drug delivery ocular implant comprising:
an outer shell defining a drug reservoir and comprising a plurality of orifices;
a drug disposed within the drug reservoir; and
a hydrogel disposed within the drug reservoir, at least a portion of the hydrogel positioned between the plurality of orifices and at least a portion of the drug.
32 . The drug delivery ocular implant of claim 31 , wherein the plurality of orifices are positioned at a distal end of the outer shell and wherein the hydrogel is a hydrogel plug positioned at or near the distal end of the outer shell and adjacent the drug.
33 . The drug delivery ocular implant of claim 31 , wherein a first set of orifices of the plurality of orifices is positioned at or near a distal end of the outer shell and a second set of orifices of the plurality of orifices is positioned at or near a proximal end of the outer shell, and
wherein the drug and the hydrogel form a hydrogel-drug mixture.
34 . The drug delivery ocular implant of claim 31 , wherein a first set of orifices of the plurality of orifices is positioned at or near a distal end of the outer shell and a second set of orifices of the plurality of orifices is positioned at or near a proximal end of the outer shell, and
wherein the hydrogel surrounds the drug.